Acute myeloid leukemia with BCR-ABL1

Clinical trials for Acute myeloid leukemia with BCR-ABL1 explained in plain language.

Never miss a new study

Get alerted when new Acute myeloid leukemia with BCR-ABL1 trials appear

Sign up with your email to follow new studies for Acute myeloid leukemia with BCR-ABL1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Promising combo targets tough leukemia

Disease control Ongoing

This study tests a new way to treat adults with a specific type of leukemia (Ph+ ALL) that has come back or not responded to treatment. The approach combines low-intensity chemotherapy with two targeted drugs, ponatinib and blinatumomab, to kill cancer cells and boost the immune …

Matched conditions: ACUTE MYELOID LEUKEMIA WITH BCR-ABL1

Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Aug 21, 2026 00:00 UTC

Acute myeloid leukemia with BCR-ABL1

Get alerted when new Acute myeloid leukemia with BCR-ABL1 trials appear

Promising combo targets tough leukemia